Investment advisor services

Who we are

Capital

Clinical

Commercialization

Not only possess capital funds, but also have conviction that in-depth knowledge of clinical development and rich experience in commercialization stage go hand in hand.

What We Do

Quality

Customization

Profitability

We make talent an integral part of every major strategic decision and package our products in a nutshell.

Why Choose Us

In-Depth Experience

Ample Connection

First-Class Advices

With experts hands-on to provide active support and ongoing commitment that create the future for biotech and healthcare industry.

Who We Are

Eminent Capital Partners is an investment company that aims to provide one-stop service to give customized solutions to their clients with new inventions of biotech and healthcare products who are looking to incubate into Asia Pacific market, in particular the Chinese market. With our “3C” strategy, we ensure that our professional scientific skills are woven into the fabric of our company, linking talent to business gold, maximizing investment returns. Enhanced with a diversity of minds, we accumulate cost-efficient and time-saving strategies to unlock the secret of healthcare and biotech industry and bring them into China.

What We Do

With deep-rooted commitment, we translate talent to value, and reinforce the next level of productivity gains and efficiencies. We support our clients to make continuous improvement, whether to raise money, to consult legally or to manage risk, aiming to help them foster, develop and bloom. We address the needs of our clients; craft a well-established business strategy via thorough and careful approach; and advise them using our in-depth knowledge on healthcare and biotech industry in China.

Why Choose Us

Our Uniqueness

Old competitors are catching up. New competitors are popping up. We reinforce the quality of our products. With each client engagement Eminent Capital Partners maintains stringent and disciplined adherence to pre-determined end goals of providing comprehensive support throughout the entire fragmented process. Our long-tenured professionals apply their experience and expertise across the entire process from upstream research to downstream commercialization, in order to sustain the quality, to improve the value, and to maximize returns of selected projects. Brick-by-brick, we pave way for selected biotech and healthcare projects, accommodating them with a strategic and well-developed plan to penetrate into Chinese market successfully.

We’ve Got Your Back

We fulfill the objective of product suitability, market opportunity, and best execution. With a perpetual bond with our partner, HKBMIA (Hong Kong Bio-Med Innotech Association), and PhIRDA (China Pharmaceutical Innovation and Research Development Association), Eminent Capital Partners gains access to first-in-hand information as well as advanced technologies which ensures better quality of projects in which we invest. The right development strategy is critical to the future of your project and your company. We apply best-in-class advices to pave a scrupulous route for our projects to launch into the Chinese market using our deep understanding of the Chinese regulatory system. Served with heart, we cultivate new capabilities to businesses, and we connect your project with expertise and get you there.

Explore Our Capabilities

Fund Raising

Bringing a breadth of expertise on executing excellence on complex transactions, we thrive to link our clients to capital, supported by our strong financial stance. From our specialization and experience in biotech and healthcare industry, we not only understand the current market value but also its potential opportunity. We therefore understand the challenges and concerns encountered by foreign biotech firms. We formulate fund structure design and optimization, draft relevant legal documents for fund establishment, and handle relevant approval. Rather than merely raising funds, with unswerving commitment, we raise funds for our selected projects dedicated to continue spurring their development

Financial Advisory

With intimate knowledge of the financial players, we provide best-in-class advice and services related to a wide range of transaction types, including M&A, financing, restructuring, pre-IPO etc. We identify the risks, assess specific problems and design client-oriented transaction structures along with the provision of a reference for pricing. We uncover your weaknesses, pinpoint the obstacles you are facing, and thereby applying diversified insights to source and capture investment opportunities in the healthcare and biotech industry environment, using concrete solution to help transform projects into businesses

Corporate Structure & Governance

With deep understanding of Hong Kong’s regulatory environment, we focus on providing legal advices and encompass an environment of effective oversight and rigid accountability with professional board members, ensuring to align our clients with proper corporate strategies. We are aware of the possible negative impact resulted from legal violations. With rigid relationships with governmental departments, we work side-by-side to protect your business reputation as our basis of success, minimizing legal risks through a consolidated plan for best practices and well-established internal controls.

Valuation

Legal Advice

Our philosophy is to combine worldwide and Chinese legal practices to deliver value to our clients that is consistent with their business objectives. With long-tenured experts, we commit to convey client-oriented solutions with coordinated, cogent legal advices. We acknowledge the importance of legal counsel, promising to address critical needs of our clients. We generate practical, cost-effective legal solutions, dedicated to ensure the right path to penetrate into the Chinese market.

IP Protection

With ample experience in handling patent disputes related to healthcare and pharmaceutical industry, we deeply understand the patent linkage issues, and recognise the legal challenges that foreign firms encounter. We have both US and Chinese patent agents/attorneys who can practice directly before the USPTO and SIPO, and have one of the most experienced and sophisticated practices in global life science IP practice in Greater China. Utilizing our unique understanding of Western and Eastern culture and patent law, we serve as an effective bridge that connect the US, Europe, China and the rest of the world together for our clients who need IP services. We protect our clients’ rights against infringers, assess competition law risks inherent in patent infringement actions, and make preparation in advance with holistic approach to reduce such risk, thereby cultivating a solid and secure core for business development to improve the competitiveness of our clients.

Regulatory Affairs

We provide regulatory affairs advice; address specific needs of the company; and help planning and managing their pharmaceutical and medical product development programs and regulatory requirements.

Our qualified experts provide consulting advice that covers from early pre-IND/pre-CTA/pre-IDE stage of pharmaceutical development to marketing applications. We work with sponsors and regulatory authorities through the resolution of complex development issues.

On the other hand, we are also experienced in offering full service regulatory support for medical device and diagnostic development.

Clinical Research Planning

Over 20 years of CRO experience in China and Asia Pacific serving international pharmaceutical companies such as GSK, Merck, Novartis, etc, our objective is to assist you to optimize your clinical trial design for clinical and commercial success in China with an efficient, systematic approach:

Leverage your existing data form your origin country and seek for China agency recognition
Gain KOL recognition and support for your clinical study
Perform pre-IND meeting with CFDA reviewer to prepare and strategize your study that fulfills CFDA regulatory expectation
Propose the most effective protocol design for your clinical trial in China to be executed with greater confidence and predictability
Customize your clinical trial project in China with the most cost-efficient strategic approach for quality and performance

With an ample range of services from feasibility assessment, site selection, protocol development to CSR writing and NDA application, we translate information into actionable insights to enable better informed strategic decisions and bring unique success to your clinical studies in China

Contract Development Manufacturing

Stronger know-how, wider global network, and better technology make up dedicated to apply international quality standards to support innovative Chinese and international companies to industrialize their research results.

Offer tailor-made contract development and manufacturing services of antibodies and biologics for clients in China and globally
Stable and steady platform designed to support our client from the initial product concept to the approved pharmaceutical drug
Deliver a large number of pharmaceuticals in a variety of dosage forms, requiring the use of a broad range of technologies.

Project Advisory & Development

Cost-effectiveness, time-saving strategy and a well-developed plan are at the heart of our objective. Based on our thorough understanding of specific needs and objectives of our selected projects, we recognise the fundamentals of maximizing the value of our clients. Through detailed analysis of project’s up-to-date status, we consolidate and leverage its data; we work comprehensively with CFDA and KOLs, designing cost-efficient strategies and crafting a well-established project plan to get approval from CFDA. We also develop a tailored exit strategy as an IPO in Hong Kong, to achieve a one-stop solution for the project owner, to unleash and launch the product in China with the lowest cost and shortest possible time.

Project Commercialization

Being experienced in establishing JV partnership, negotiating distribution rights, sharing your royalty as well as successful licensing deals, we possess a deep-rooted understanding of the market for healthcare and biotech industry, from its present to its future, our experienced experts hands-on to execute concise commercialization plan with rigorous approach, involving out-licensing, joint venture and distribution, in order to successfully launch our clients’ products. Supported with connections and partnerships with more than 100 companies ranging from biotech to pharmaceutical area in China, we shape our projects with strategic priorities and thrive to find a suitable local partner. Through disciplined negotiations, we pursue to improve the connection between foreign biotech firms and the Chinese market, setting out a smooth and effective path for the journey to commercialization.

Capital

Clinical

Commercialization

Quality

Customization

Profitability

In-Depth Experience

Ample Connection

First-Class Advices

Who We Are

What We Do

Why Choose Us

Explore Our Capabilities

Fund Raising

Financial Advisory

Corporate Structure & Governance

Valuation

Legal Advice

IP Protection

Regulatory Affairs

Clinical Research Planning

Contract Development Manufacturing

Project Advisory & Development

Project Commercialization

Scientific Advisory Committee